Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.77−0.04 (-5.03%)
Close on Nov 13, 2026Market cap $8.96MP/E –Yield –
Phio Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Phio Pharmaceuticals's total assets was $11.32M at Sep 30, 2026. For fiscal 2025 it was $21.49M, up 274.5% from the year before. Over ten years it grew 6.8% a year on average. The highest annual figure on record is $25.17M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.49M | +274.5% |
| FY2024 | Dec 31, 2024 | $5.74M | -38.7% |
| FY2023 | Dec 31, 2023 | $9.36M | -26.9% |
| FY2022 | Dec 31, 2022 | $12.81M | -49.1% |
| FY2021 | Dec 31, 2021 | $25.17M | +59.9% |
| FY2020 | Dec 31, 2020 | $15.74M | +95.8% |
| FY2019 | Dec 31, 2019 | $8.04M | -47.5% |
| FY2018 | Dec 31, 2018 | $15.32M | +273.9% |
| FY2017 | Dec 31, 2017 | $4.10M | -69.4% |
| FY2016 | Dec 31, 2016 | $13.40M | +20.1% |
| FY2015 | Dec 31, 2015 | $11.16M | +21.4% |
| FY2014 | Dec 31, 2014 | $9.19M | -38.5% |
| FY2013 | Dec 31, 2013 | $14.94M | +167.1% |
| FY2012 | Dec 31, 2012 | $5.59M | +230.1% |
| FY2011 | Dec 31, 2011 | $1.69M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.32M | -1.6% |
| Q2 FY2026 | Jun 30, 2026 | $14.31M | +26.6% |
| Q1 FY2026 | Mar 31, 2026 | $17.41M | +29.6% |
| Q4 FY2025 | Dec 31, 2025 | $21.49M | +274.5% |
| Q3 FY2025 | Sep 30, 2025 | $11.51M | +96.2% |
| Q2 FY2025 | Jun 30, 2025 | $11.30M | +113.4% |
| Q1 FY2025 | Mar 31, 2025 | $13.44M | +96.1% |
| Q4 FY2024 | Dec 31, 2024 | $5.74M | -38.7% |
| Q3 FY2024 | Sep 30, 2024 | $5.87M | -38.5% |
| Q2 FY2024 | Jun 30, 2024 | $5.30M | -56.9% |
| Q1 FY2024 | Mar 31, 2024 | $6.85M | -29.4% |
| Q4 FY2023 | Dec 31, 2023 | $9.36M | -26.9% |
| Q3 FY2023 | Sep 30, 2023 | $9.54M | -39.6% |
| Q2 FY2023 | Jun 30, 2023 | $12.30M | -39.0% |
| Q1 FY2023 | Mar 31, 2023 | $9.71M | -56.2% |
| Q4 FY2022 | Dec 31, 2022 | $12.81M | -49.1% |
| Q3 FY2022 | Sep 30, 2022 | $15.79M | -43.5% |
| Q2 FY2022 | Jun 30, 2022 | $20.14M | -36.4% |
| Q1 FY2022 | Mar 31, 2022 | $22.16M | -34.5% |
| Q4 FY2021 | Dec 31, 2021 | $25.17M | +59.9% |
| Q3 FY2021 | Sep 30, 2021 | $27.94M | +53.2% |
| Q2 FY2021 | Jun 30, 2021 | $31.66M | +56.6% |
| Q1 FY2021 | Mar 31, 2021 | $33.86M | +136.7% |
| Q4 FY2020 | Dec 31, 2020 | $15.74M | +95.8% |
| Q3 FY2020 | Sep 30, 2020 | $18.24M | +81.0% |
| Q2 FY2020 | Jun 30, 2020 | $20.21M | +66.9% |
| Q1 FY2020 | Mar 31, 2020 | $14.31M | +4.6% |
| Q4 FY2019 | Dec 31, 2019 | $8.04M | -47.5% |
| Q3 FY2019 | Sep 30, 2019 | $10.08M | +164.6% |
| Q2 FY2019 | Jun 30, 2019 | $12.11M | +100.8% |
| Q1 FY2019 | Mar 31, 2019 | $13.68M | +342.7% |
| Q4 FY2018 | Dec 31, 2018 | $15.32M | +273.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.81M | -36.9% |
| Q2 FY2018 | Jun 30, 2018 | $6.03M | -28.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.09M | -70.6% |
| Q4 FY2017 | Dec 31, 2017 | $4.10M | -69.4% |
| Q3 FY2017 | Sep 30, 2017 | $6.03M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.39M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.40M | – |
See a number that looks wrong?